Infections: Clinical Trials

46,360 trials for Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28927 completed, 7193 unknown, 3043 recruiting, 2670 terminated. 11275 Not applicable, 7993 Phase 2, 6115 Phase 3, 5939 Phase 1, 4099 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable11275Completed 6841, Unknown 1847, Recruiting 881, Terminated 512, Not yet recruiting 451, Withdrawn 327, Active not recruiting 299, Enrolling by invitation 79, Suspended 38
Phase 27993Completed 5013, Unknown 885, Terminated 802, Recruiting 441, Withdrawn 394, Active not recruiting 227, Not yet recruiting 185, Suspended 32, Enrolling by invitation 14
Phase 36115Completed 4129, Unknown 696, Terminated 486, Recruiting 285, Withdrawn 216, Active not recruiting 149, Not yet recruiting 121, Suspended 28, Enrolling by invitation 5
Phase 15939Completed 4282, Unknown 448, Terminated 411, Recruiting 292, Withdrawn 224, Active not recruiting 142, Not yet recruiting 115, Enrolling by invitation 14, Suspended 11
Phase 44099Completed 2509, Unknown 687, Terminated 320, Recruiting 212, Withdrawn 145, Not yet recruiting 118, Active not recruiting 78, Enrolling by invitation 18, Suspended 12
Early Phase 1349Completed 147, Unknown 76, Recruiting 35, Not yet recruiting 33, Terminated 20, Withdrawn 19, Active not recruiting 14, Suspended 3, Enrolling by invitation 2

Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.
CYFENDUS - Anthrax
Not yet recruitingEmergent BioSolutions2502035-11-012025-12-08
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart
Phase 2SuspendedG&E Herbal Biotechnology Co., LTD1022030-09-012023-09-14
Assessment of Myocarditis After Replication-Deficient Smallpox Immunization
JYNNEOS - Myopericarditis, Small Pox
Not yet recruitingWomack Army Medical Center23502029-03-012023-12-14
Antibiotics for Kidney Transplant Recipients
Trimethoprim-Sulfamethoxazole (TMP-SMX), Usual Care - Kidney Transplant, Urinary Tract Infection(UTI)
Phase 4Not yet recruitingUniversity of California, San Francisco502028-10-012026-09-11
Evaluating a Clinical Decision Support Tool for Antiretroviral Therapy Optimization
smART (Smart Antiretroviral Therapy Assistant), Traditional Prescribing resources - HIV (Human Immunodeficiency Virus), Clinical Decision Support System (CDSS)
Not applicableNot yet recruitingKeck School of Medicine of USC2502028-09-012025-10-22
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
Bubble CPAP Team-Based Care Strategy Feasibility Trial
bCPAP team-based care strategy - Pneumonia in Children
Not applicableNot yet recruitingYale University952028-04-012026-06-02
Improving Clinic Delivery of HIV-related Anal Health Services
PEACHES 2.0 Implementation Strategies - HIV, Gonorrhea
Not applicableNot yet recruitingAlbert Einstein College of Medicine82028-02-012026-10-13
OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren
Monthly DP, Quarterly DP - Malaria, Asymptomatic Malaria
Phase 3Not yet recruitingIndiana University15002028-01-012026-09-01
School-Based Bladder Health Intervention
Bladder Health Education - Urinary Dysfunction, Lower Urinary Tract Symptoms
Not applicableWithdrawnStanford University2028-01-012026-05-07
Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV
Brief Videos for HIV Stigma - HIV, Mental Health
Not applicableNot yet recruitingCity University of New York, School of Public Health39002028-01-012026-10-01
Effects of Food Intake on Biomarker Activity in Normal Humans Taking Immulina
Immulina, Placebo - Viral Diseases
Phase 2Not yet recruitingUniversity of Mississippi Medical Center2502028-01-012026-10-23
Extended vs. Intermittent Meropenem Infusion in Sepsis Patients in the ICU
Extended beta-lactam antibiotics, Intermittent Beta-lactam antibiotics - Sepsis, Septic Shock
Not yet recruitingAssiut University902027-10-012026-09-01
Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations
SD-ART - Hiv
Not applicableNot yet recruitingYale University1392027-10-012026-08-31
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone - Human Papillomavirus (HPV) Vaccines
Not applicableNot yet recruitingUniversity of Florida12962027-09-152026-09-14
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy
• Sivelestat intravenous infusion, NaCl intravenous infusion - Septic Shock, Coagulopathy
Phase 2Not yet recruitingUniversity Hospital, Strasbourg, France1202027-08-012026-08-20
Against Chikungunya Virus and Neonatal Infection
plasma transfusion : PC-CHIK-V - Chikungunya Virus Infection, Neonatal
Not applicableRecruitingCentre Hospitalier Universitaire de la Réunion602027-08-012026-09-15
Perceptions of Undergraduate Students and Teaching Staff on Online Teaching
Questionnaire - Covid19
SuspendedMisr International University92092027-07-152026-10-08
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV)
Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections
Not applicableNot yet recruitingHifas da Terra S.L.812027-07-012026-10-05
Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria
Coartem® Baby - Malaria
Phase 4Not yet recruitingNovartis Pharmaceuticals202027-06-182026-07-20

Showing 20 of 46360. Sign in to see all of them.

Narrower conditions

COVID-19 (7572)  ·  HIV Infections (4677)  ·  Acquired Immunodeficiency Syndrome (3030)  ·  Sepsis (2294)  ·  Influenza, Human (2160)  ·  Hepatitis C (1719)  ·  Pneumonia (1388)  ·  Tuberculosis (1144)  ·  Malaria (1134)  ·  Coronavirus Infections (1111)  ·  Shock, Septic (1060)  ·  Hepatitis B (1001)  ·  Burkitt Lymphoma (974)  ·  Hepatitis C, Chronic (907)

Broader conditions

Virus Diseases (25647)  ·  RNA Virus Infections (21208)  ·  Respiratory Tract Diseases (15313)  ·  Pathological Conditions, Signs and Symptoms (14084)  ·  Respiratory Tract Infections (13957)  ·  Pathologic Processes (12461)  ·  Communicable Diseases (11473)  ·  Lung Diseases (11381)  ·  Blood-Borne Infections (10364)  ·  Urogenital Diseases (10029)  ·  Immune System Diseases (8955)  ·  Pneumonia (8700)  ·  Genital Diseases (8506)  ·  Nidovirales Infections (8335)

Interventions

Ribavirin (702)  ·  Blood Specimen Collection (481)  ·  Standard of Care (448)  ·  Influenza Vaccines (446)  ·  peginterferon alfa-2a (425)  ·  Ritonavir (419)  ·  Saline Solution (396)  ·  Sodium Chloride (390)  ·  Tenofovir (388)  ·  Lamivudine (325)  ·  Zidovudine (322)  ·  Azithromycin (294)  ·  Cyclophosphamide (277)  ·  efavirenz (224)  ·  Surveys and Questionnaires (218)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (1909)  ·  GlaxoSmithKline (1185)  ·  Merck Sharp & Dohme LLC (536)  ·  Pfizer (452)  ·  Assistance Publique - Hôpitaux de Paris (432)  ·  Sanofi Pasteur, a Sanofi Company (339)  ·  Assiut University (316)  ·  University of Oxford (293)  ·  University of California, San Francisco (290)  ·  Gilead Sciences (283)  ·  National Cancer Institute (NCI) (271)  ·  ViiV Healthcare (256)  ·  Hoffmann-La Roche (244)  ·  Bristol-Myers Squibb (220)  ·  University of North Carolina, Chapel Hill (210)

Countries

United States (14602)  ·  France (3423)  ·  China (3053)  ·  Canada (2130)  ·  United Kingdom (1979)  ·  Spain (1906)  ·  Germany (1846)  ·  Italy (1663)  ·  Brazil (1260)  ·  Turkey (Türkiye) (1141)  ·  Belgium (1078)  ·  Australia (1072)  ·  South Africa (1026)  ·  South Korea (916)  ·  Netherlands (901)

Results publications

PMID 34473343, PMID 41276263, PMID 35244208, PMID 31986264, PMID 35713300, PMID 41671463, PMID 32031570, PMID 26903338, PMID 32109013, PMID 32091533, PMID 32171076, PMID 34013969, PMID 36734509, PMID 37162745, PMID 41159585, PMID 33502773, PMID 37068952, PMID 37781954, PMID 37947276, PMID 38700045, PMID 39324693, PMID 39807668, PMID 36695483, PMID 30739368, PMID 32779730, PMID 34658014, PMID 37489818, PMID 37591523, PMID 35622074, PMID 37010196, PMID 40190112, PMID 40260835, PMID 25820067, PMID 30977945, PMID 32167524, PMID 32813276, PMID 40099800, PMID 30012435, PMID 30923816, PMID 32335895, PMID 33215698, PMID 34350582, PMID 28193518, PMID 29461687, PMID 31568620, PMID 32142651, PMID 32192578, PMID 32250385, PMID 33305842, PMID 33616229

NIH funding

2014 (138), 2023 (127), 2015 (125), 2019 (121), 2009 (106), 2016 (104), 2018 (98), 2008 (89), 2017 (86), 2025 (77), 2005 (39), P30CA033572 (29), P30CA015704 (28), 2004 (27), U01AI068636 (27)